NEW DELHI (February 23, 2026) — The initial public offering (IPO) of Gaudium IVF and Women Health, a prominent provider of fertility services, was fully subscribed on its second day of share sales on Monday. According to data from the National Stock Exchange (NSE), the offering saw significant traction from retail and non-institutional investors, comfortably surpassing the total number of shares available by midday.
Subscription Data and Investor Categories
As of 12:30 hours, the company received bids for 28,563,948 shares against an offering of 14,620,340 shares. This indicates a subscription rate of 1.95 times the initial volume. The demand was primarily driven by smaller-scale investors, while institutional interest remained subdued during the early stages of the bidding process.
The breakdown of the subscription by investor category is as follows:
| Investor Category | Subscription Rate |
| Retail Individual Investors | 2.81 times |
| Non-Institutional Investors | 2.56 times |
| Qualified Institutional Buyers (QIBs) | 0.01 times (1%) |
Company Background and Market Context
Gaudium IVF and Women Health operates within the rapidly expanding reproductive healthcare sector in India. The capital raised through this public listing is expected to fund the company’s expansion and the enhancement of its clinical infrastructure.
Whilst retail and non-institutional segments showed robust appetite for the shares, the Qualified Institutional Buyers (QIB) portion typically sees increased activity towards the final day of an IPO, a common trend in the Indian capital markets.
Sources
- National Stock Exchange (NSE) Live IPO Data (February 23, 2026)
- Press Trust of India (PTI) / Economic Times: “Gaudium IVF’s IPO gets fully subscribed on day 2” (February 23, 2026)
Leave a Reply